Vancomycin Hydrochloride 500 mg/1 (Vancomycin Hydrochloride INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 500 mg/1

Vancomycin Hydrochloride 500 mg/1 is a lyophilized powder for solution, used for intravenous administration. It is commonly prescribed for serious bacterial infections. This product is manufactured by Hospira, Inc. in the USA.

Strength

500 mg/1

Pack Size

10 VIAL in 1 TRAY (0409-4332-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0409-4

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vancomycin Hydrochloride is primarily used to treat severe bacterial infections, including those resistant to other antibiotics. It is often administered intravenously to combat infections caused by gram-positive bacteria. This medication is frequently used in hospital settings for conditions like sepsis, endocarditis, and bone infections.

Side Effects

Common effects of Vancomycin Hydrochloride may include infusion-related reactions such as redness or pain at the injection site. Some patients may experience hearing loss, kidney problems, or allergic reactions. It is important to monitor for any adverse effects during treatment.

Precautions & Warnings

Vancomycin Hydrochloride should be handled with care, ensuring proper reconstitution and administration to avoid complications. Patients with pre-existing kidney issues should be monitored closely. Always follow healthcare provider instructions for safe use.

Avoid Interactions

Vancomycin Hydrochloride may interact with other medications, including aminoglycosides and loop diuretics, which can increase the risk of kidney damage. It is important to inform healthcare providers about all medications being taken to avoid potential interactions.

Frequently Asked Questions

Vancomycin Hydrochloride is used to treat serious bacterial infections, often when other antibiotics are ineffective.

Vancomycin Hydrochloride is administered intravenously after reconstitution of the lyophilized powder.

Common side effects may include infusion-related reactions, hearing loss, and kidney problems.

Vancomycin Hydrochloride may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Vancomycin Hydrochloride is manufactured by Hospira, Inc. in the USA.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.